Objectives The aim of this article was to review the current role of brain PET in the diagnosis
of Alzheimer dementia. The characteristic patterns of glucose metabolism on brain FDG-PET …

There is increasing use of neuroimaging modalities, including PET, for diagnosing
dementia. For example, FDG-PET demonstrates hypometabolic regions in the posterior …

OBJECTIVE. We review the role of brain FDG PET in the diagnosis of Alzheimer disease,
frontotemporal dementia, dementia with Lewy bodies, and vascular dementia. Characteristic …

Purpose By 2050 it is projected that 115 million people worldwide will have Alzheimer's
Disease (AD)[1]. Recent attempts have been made to redefine the diagnostic criteria of AD …

The demographics of aging suggest a great need for the early diagnosis of dementia and
the development of preventive strategies. Neuropathology and structural MRI studies have …

Clinical use of positron emission tomography (PET) is now well established in
neurodegenerative disorders, especially in the diagnosis of dementia. Measurement of …

Beta amyloid plaques, neurofibrillary tangles, and impaired glucose metabolism are among
the most prevalent pathological characteristics of Alzheimer's disease (AD). However …

The diagnosis of dementia syndromes can be challenging for clinicians, particularly in the
early stages of disease. Patients with higher education levels may experience a marked …

Objective The objective of the study is to compare the diagnostic value of regional sampling
of the cerebral metabolic rate of glucose metabolism (MRglc) using [18F]-fluoro-2 …

Measurement of local cerebral glucose metabolism (lCMRGlc) by positron emission
tomography (PET) and 18 F-2-fluoro-2-deoxy-d-glucose (FDG) has become a standard …